D. Hope White
Novartis (Switzerland)(CH)Novartis (United States)(US)Tris Pharma (United States)(US)
Publications by Year
Research Areas
Synthesis and Reactions of Organic Compounds, Synthesis of heterocyclic compounds, Organic and Inorganic Chemical Reactions, Asymmetric Synthesis and Catalysis, Synthesis and biological activity
Most-Cited Works
- → Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors(1993)34 cited
- → Omphalophloios, a new lepidodendroid type(1897)11 cited
- → Benzoxepin and benzothiepin derivatives as potent, orally active inhibitors of 5-lipoxygenase(1994)7 cited
- → Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy model(1997)7 cited
- → Leukotriene biosynthesis inhibition by aryl and aroyl substituted naphthoquinones(1991)5 cited
- → CGS 22745: A selective orally active inhibitor of 5-lipoxygenase(1991)4 cited
- Characterization of CGS 8515 as a selective 5-lipoxygenase (5-LO) inhibitor.(1989)
- → ChemInform Abstract: Benzoxepin and Benzothiepin Derivatives as Potent, Orally Active Inhibitors of 5‐Lipoxygenase.(1994)